Global pharma manufacturer scaling rare disease and specialty care across 150 markets
Recordati is a century-old Italian pharmaceutical manufacturer now operating as a public company with over 4,500 employees across 25+ countries. The tech stack is heavily SAP-centric (ECC, S/4HANA, MM, Master Data Governance, IBP) paired with Veeva for regulatory and SuccessFactors for talent management—a pattern typical of mature, operationally complex pharma organizations. Hiring is sales-dominant (75 open roles) with notable gaps in engineering (7 roles), signaling a business optimized for commercial execution and regulatory compliance rather than software-led innovation.
Notable leadership hires: Regional Business Director, Hospital Account Director, Business Director, Marketing Director, Franchise Head Rare Diseases
Recordati develops and commercializes medicines across specialty care and rare diseases, serving patients in approximately 150 countries. The company operates three distinct business pillars: primary care and specialty drugs (mass-market diseases), rare disease treatments, and industrial pharmaceutical operations. Revenue is generated through direct-to-healthcare-provider sales (HCP relationships, formulary access, academic medical center engagement) and international licensing. Current strategic focus includes expanding rare disease market share, transforming the sales organization, and improving treatment access and patient awareness across key therapeutic areas like Cushing's disease.
SAP-dominant (ECC, S/4HANA, MM, Master Data Governance, IBP), supplemented by Veeva for life sciences compliance, SAS for analytics, SuccessFactors for HR, Salesforce and HubSpot for sales/marketing, and Tableau for reporting.
Yes. Sales has 75 active open roles (38% of total hiring), with recent postings for Regional Business Director, Hospital Account Director, and Business Director positions across Europe, US, and emerging markets.
Recordati actively recruits across 25 countries including Italy, Poland, Germany, Belgium, US, Spain, France, UK, and emerging markets in Turkey, Peru, South Korea, Brazil, and Central Asia.
Other companies in the same industry, closest in size